Genome-based oral and pharyngeal tumor inhibition in migration assays

This is a cross-sectional controlled study that aims at developing experimental invasion-modulating approaches from genome-wide knowledge. We use clinical samples from patients with oral and/or pharyngeal tumor. Clinical significance is to try to develop predictive markers, individualized drugs and 3D drug-sensitivity tests for patients with oral and pharyngeal carcinoma.